Lucid Scientific
Lucid Scientific designs and sells Resipher, a non-invasive metabolic cell analyzer that turns standard 96-well plates into continuous oxygen consumption readers for bioenergetic research, serving academic, pharmaceutical/biotech, and CRO customers.
- Company typePrivate
- Founded2012
- HeadquartersAtlanta, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lucid Scientific does
Lucid Scientific, Inc. is a privately held biotechnology instrumentation company headquartered in Atlanta, Georgia, founded in 2012 and Delaware-incorporated. The company designs, develops, and sells Resipher, a non-invasive metabolic cell analyzer that converts standard 96-well plates into real-time, dynamic oxygen consumption readers. Resipher enables continuous bioenergetic profiling — measuring mitochondrial electron transport chain function, fatty acid oxidation substrate metabolism, ATP-linked respiration, spare capacity, and proton leak — across experiments lasting days to months without disrupting standard incubator workflows. The platform supports 2D monolayers, 3D organoids, tissue slices, embryos, and whole organisms in multiple plate formats.
The company targets three primary customer segments: academic research institutions conducting metabolic and bioenergetics studies, pharmaceutical and biotechnology companies using metabolic profiling for drug discovery and preclinical toxicity testing, and contract research organizations providing metabolic analysis services. Its go-to-market is a direct sales motion combining website-enabled purchases ('Buy today', 'Purchase a system') and enterprise demo requests, supported by HubSpot-integrated lead management and a digital content strategy centered on publications, how-to videos, and technical documentation. Revenue is generated primarily through Resipher hardware sales with an implied recurring component from plates and related consumables; pricing is not publicly disclosed.
Lucid Scientific has raised approximately $10.1 million in cumulative funding across small Georgia Research Alliance grants (2018–2019), a $3M seed round in 2020 led by Dynamk Capital, and a $7M Series A in September 2023 led by IAG Capital Partners. The company operates with 11–50 employees and has no disclosed partnerships, acquisitions, or AI/ML capabilities.
Lucid Scientific firmographics
Firmographics- Name
- Lucid Scientific
- Legal name
- Lucid Scientific, Inc.
- Website
- https://lucidsci.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Lucid Scientific designs and sells Resipher, a non-invasive metabolic cell analyzer that turns standard 96-well plates into continuous oxygen consumption readers for bioenergetic research, serving academic, pharmaceutical/biotech, and CRO customers.
- Ownership category
- akta.pro rank
Lucid Scientific industry classification
Industry- Product category
- Laboratory Analytical Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)
Keywords
Where Lucid Scientific is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Lucid Scientific business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Resipher System Sales: Sale of the Resipher non-invasive metabolic cell analyzer hardware system. The product turns standard 96-well plates into precise dynamic oxygen consumption readers for bioenergetic research applications.
- Consumables and Accessories: Implied recurring revenue from plates and related consumables for ongoing laboratory research workflows.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Lucid Scientific product offering
Product offeringCore offering
Lucid Scientific designs, develops, and sells Resipher, a non-invasive metabolic cell analyzer that converts standard 96-well plates into dynamic oxygen consumption readers for continuous bioenergetic profiling. The instrument measures mitochondrial ETC function, FAO substrate metabolism, ATP-linked respiration, spare capacity, and proton leak over experiments lasting days to months, integrating directly into standard laboratory incubator workflows. The company sells hardware systems with associated consumables and accessories to academic, pharmaceutical, and biotech research customers.
Product overview
Lucid Scientific offers a single unified product, Resipher, a continuous bioenergetics platform for non-invasive metabolic cell analysis. Resipher enables bioenergetic profiling of mitochondrial ETC function and FAO substrate metabolism using standard 96-well plates, with the ability to measure functional parameters including ATP-linked respiration, spare capacity, and proton leak over experiments lasting days to months.
Differentiator
Problem solved
Functional benefit
Brands
- Resipher: Non-invasive metabolic cell analyzer for continuous bioenergetic profiling of mitochondrial ETC function, FAO substrate metabolism, and long-term baselines for stable basal respiration.
- Continuous Bioenergetics
Products and services
- Resipher Non-invasive metabolic cell analyzer that converts standard 96-well plates into precise dynamic oxygen consumption readers, enabling continuous bioenergetic profiling of mitochondrial ETC function, FAO substrate metabolism, ATP-linked respiration, spare capacity, and proton leak over days-to-months-long experiments for academic, pharmaceutical, biotech, and CRO researchers.
Companies that use Lucid Scientific
Customer profileSegments3 records
Ideal customer profiles3 records
Lucid Scientific technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Lucid Scientific partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Lucid Scientific competitors and assessment
Company assessmentDirect peers
- Agilent Technologies: Agilent owns the Seahorse XF analyzer, the dominant instrument for real-time cellular bioenergetics measurement. It is the most direct competitor to Lucid Scientific's Resipher, targeting the same academic and pharma customers with a similar oxygen consumption-based value proposition and a much larger installed base and consumables catalog.
- Nanion Technologies: Nanion manufactures the Oroboros O2k high-resolution respirometer for cellular and mitochondrial oxygen consumption analysis. It directly competes with Resipher in real-time metabolic profiling and shares a focus on research-grade instrumentation for bioenergetics applications.
- PreSens Precision Sensing: PreSens is a specialty manufacturer of optical oxygen and pH sensors, including microplate-based respirometry systems that compete directly with Resipher's optical oxygen consumption measurement technology in cell metabolism research.
Broad incumbents
- Bruker Corporation: Bruker is a large analytical instruments company with a portfolio spanning mass spectrometry, NMR, and cellular/molecular analysis tools. While not focused exclusively on real-time cell metabolism, it competes in the broader life science research instruments market and serves overlapping academic and pharma customers.
- Thermo Fisher Scientific: Thermo Fisher is the largest life sciences tools company, offering cell analysis instruments, microplate readers, and consumables that overlap with Lucid Scientific's target market. Its CellInsight and similar platforms represent adjacent competition for cell-based metabolic and phenotypic assays.
- Sartorius AG: Sartorius is a major bioprocessing and cell analysis company with products spanning cell line development, live-cell analysis (Incucyte), and lab consumables. Its broader portfolio of cell-based analytical tools competes for the same biopharma R&D budgets that fund Resipher purchases.
- Revvity: Revvity (formerly PerkinElmer's Life Sciences business) provides a wide range of life science research tools including cell-based assays, imaging, and analytical reagents. It addresses overlapping customer needs in drug discovery and translational research.
Emerging players
- Promega Corporation: Promega develops cell-based luminescence and fluorescence assay tools, including metabolism-relevant readouts that compete at the assay level with Resipher's bioenergetic measurements. It serves the same academic and pharma research segments with a focus on assay reagents rather than dedicated instruments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Lucid Scientific social profiles
Digital presenceLucid Scientific financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lucid Scientific leadership team
Management profileNumber of profiles
Profiles2 records
Lucid Scientific funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lucid Scientific M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lucid Scientific
What does Lucid Scientific do?
Lucid Scientific designs, develops, and sells Resipher, a non-invasive metabolic cell analyzer that converts standard 96-well plates into dynamic oxygen consumption readers for continuous bioenergetic profiling. The instrument measures mitochondrial ETC function, FAO substrate metabolism, ATP-linked respiration, spare capacity, and proton leak over experiments lasting days to months, integrating directly into standard laboratory incubator workflows. The company sells hardware systems with associated consumables and accessories to academic, pharmaceutical, and biotech research customers.
Is Lucid Scientific a public or private company?
Lucid Scientific is a private company. It is classified as venture growth investor backed and is currently operating.
When was Lucid Scientific founded?
Lucid Scientific was founded in 2012. It employs 11 to 50 people.
Where is Lucid Scientific based?
Lucid Scientific is headquartered in Atlanta, United States, in the North America region.
How does Lucid Scientific make money?
Two revenue lines are on record. Resipher System Sales are the primary driver. The others are consumables and Accessories.
Who are Lucid Scientific's main competitors?
Direct peers on record are Agilent Technologies, Nanion Technologies and PreSens Precision Sensing. Broad incumbents are Bruker Corporation, Thermo Fisher Scientific, Sartorius AG and Revvity. Promega Corporation is listed as an emerging player.
Does Lucid Scientific have an API?
No public API is recorded for Lucid Scientific.
What industry is Lucid Scientific in?
Lucid Scientific's product category is Laboratory Analytical Instruments. Its primary akta.pro industry code is HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.